Myron Kaplan

Myron Kaplan, listed as board member, appears in our data through filings on CorMedix Inc. shares, published by SEC (Form 4). The record holds 32 filings, for trades running from 19 August 2016 to 26 January 2026.

No open-market sale appears; the market trades are 18 purchases worth €896k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants and 2 option exercises.

The median purchase comes to €39k. On 12 out of 18 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 27 January 2026 with a share grant in CorMedix Inc. The latest purchase dates back some time: it was published 362 days ago, on 27 October 2025. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.